Theravance Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $289.0M | $639.3M | $344.7M |
| FY2017 | $326.2M | $441.4M | $89.0M |
| FY2018 | $611.8M | $560.2M | $378.0M |
| FY2019 | $632.7M | $408.8M | $58.1M |
| FY2020 | $772.8M | $469.1M | $81.5M |